Bird flu concern prompts US to award Moderna $176 million for vaccine development
![www.wired.com](https://media.wired.com/photos/6685bc4d8e2618989e172ed8/191:100/w_1280,c_limit/US-Government-Awards-Moderna-$176-Million-for-mRNA-Bird-Flu-Vaccine-GettyImages-2151865875.jpg)
US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine
As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025 to combat bird flu.